Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

1. So who is reviewing it? Any idea?
2. They are paying themselves large amounts at the expense of diluting your shares and they have no revenues. Never had any revenues. None of these companies include the sister. All fundraising, not a single dollar in sight. Ever.
3. So the trial is complete and has been. Why would the data still be "unlocked". Fishy, makes no sense. Trial data FULL READOUT should have occurred by now. The Romania fire is just an excuse. Their ELECTRONIC data should have been with the company when the trial finished... a while ago...
5. You don't just get to manipulate data, thats not how rigorous science works, they manipulated the data to try and save face because data for 75 would have been an even bigger flop.
6. They've been in penny land for years. And they will continue to be until make they have good results from IPF and CC but thats clearly a year or more away given that they are hardly enrolling. DMT for stroke is YEARS away. This is doomed for penny land for the foreseeable future.
7. It's not a long term efficacy trial... why are you commenting on long term efficacy?